Apotex won first tentative U.S. approval for generic semaglutide. Read what it could mean for glucagon-like peptide-1 access, pricing, and competition.
CordenPharma Colorado expands peptide development capacity with a new Boulder lab facility. Discover what this means for peptide drug manufacturing.
InstaMed Pharmaceuticals has reported rapid commercial traction for its InstaRelease oral dissolving strip, a patented non-injectable peptide delivery technology. The company announced a 300 percent month-over-month sales increase since its May 2025 launch and shared results from a double-blind pharmacokinetic study validating buccal absorption of glutathione as an effective alternative to traditional injection. The platform